Strumento inattivo

Azioni Juniper Pharmaceuticals Inc

Azioni

Durata

Periodo

Stile

Juniper Pharmaceuticals : Reports Second Quarter 2018 Financial and Operating Results	09/08/18
Dow Jones Industrial Average : Les valeurs à suivre à Wall Street	03/07/18
Juniper Pharmaceuticals : Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash	03/07/18
Juniper Pharmaceuticals : Reports First Quarter 2018 Financial and Operating Results	10/05/18
Juniper Pharmaceuticals : to Report First Quarter 2018 Results on May 10, 2018	01/05/18

Dirigenti	Titolo	Età	Da
Steven Fasman BRD	Director/Board Member	61	14/08/18

Amministratori	Titolo	Età	Da
Steven Fasman BRD	Director/Board Member	61	14/08/18
James Geraghty CHM	Chairman	70	26/05/15

Settore